B. Wagner

Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group [see comments]

D Ménaché, J. P. O'Malley, JB Schorr et al. · Blood · 1990 · 92 citations · Full text

Medicine, Hematology, Pharmacokinetics +12

Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group [see comments]

D Ménaché, J. P. O'Malley, Schorr Jb et al. · Blood · 1990 · 60 citations · Full text

Medicine, Hematology, Pharmacokinetics +12

COVID-19 and immigration detention in the USA: time to act

Allen S. Keller, B. Wagner · The Lancet Public Health · 2020 · 48 citations · Full text

Law, Criminology, Public Policy +12

Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group.

D Ménaché, O'Malley Jp, Schorr Jb et al. · PubMed · 1990 · 37 citations

Medicine, Hematology, Pharmacokinetics +10